215 related articles for article (PubMed ID: 36695984)
1. Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.
Grassi S; Cabitta L; Prioni S; Mauri L; Ciampa MG; Yokoyama N; Iwabuchi K; Zorina Y; Prinetti A
Neurochem Res; 2023 Jun; 48(6):1783-1797. PubMed ID: 36695984
[TBL] [Abstract][Full Text] [Related]
2. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
3. Surface Plasmon Resonance Sensing on Naturally Derived Membranes: A Remyelination-Promoting Human Antibody Binds Myelin with Extraordinary Affinity.
Vala M; Jordan LR; Warrington AE; Maher LJ; Rodriguez M; Wittenberg NJ; Oh SH
Anal Chem; 2018 Nov; 90(21):12567-12573. PubMed ID: 30231202
[TBL] [Abstract][Full Text] [Related]
4. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
5. Method of identifying natural antibodies for remyelination.
Warrington AE; Rodriguez M
J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
[TBL] [Abstract][Full Text] [Related]
6. A recombinant human IgM promotes myelin repair after a single, very low dose.
Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
[TBL] [Abstract][Full Text] [Related]
7. Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia.
Zorina Y; Stricker J; Caggiano AO; Button DC
Sci Rep; 2018 Jun; 8(1):9392. PubMed ID: 29925848
[TBL] [Abstract][Full Text] [Related]
8. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
[TBL] [Abstract][Full Text] [Related]
9. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
Watzlawik JO; Warrington AE; Rodriguez M
PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
Rosenbluth J; Schiff R; Liang WL; Dou W
J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
[TBL] [Abstract][Full Text] [Related]
11. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
[TBL] [Abstract][Full Text] [Related]
12. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain.
Pernber Z; Molander-Melin M; Berthold CH; Hansson E; Fredman P
J Neurosci Res; 2002 Jul; 69(1):86-93. PubMed ID: 12111819
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of monoclonal antibodies to the myelin glycolipid sulfatide.
Hofstetter W; Bologa L; Wetterwald A; Z'graggen A; Blaser K; Herschkowitz N
J Neurosci Res; 1984; 11(4):341-50. PubMed ID: 6379201
[TBL] [Abstract][Full Text] [Related]
14. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes.
Watzlawik J; Holicky E; Edberg DD; Marks DL; Warrington AE; Wright BR; Pagano RE; Rodriguez M
Glia; 2010 Nov; 58(15):1782-93. PubMed ID: 20645409
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease.
Mitsunaga Y; Ciric B; Van Keulen V; Warrington AE; Paz Soldan M; Bieber AJ; Rodriguez M; Pease LR
FASEB J; 2002 Aug; 16(10):1325-7. PubMed ID: 12154009
[TBL] [Abstract][Full Text] [Related]
16. The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Grassi S; Prioni S; Cabitta L; Aureli M; Sonnino S; Prinetti A
Neurochem Res; 2016 Feb; 41(1-2):130-43. PubMed ID: 26542149
[TBL] [Abstract][Full Text] [Related]
17. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes.
Dyer CA; Benjamins JA
J Neurosci Res; 1991 Dec; 30(4):699-711. PubMed ID: 1787543
[TBL] [Abstract][Full Text] [Related]
18. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
Warrington AE; Rodriguez M
Curr Top Microbiol Immunol; 2008; 318():213-39. PubMed ID: 18219820
[TBL] [Abstract][Full Text] [Related]
19. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.
Asakura K; Miller DJ; Pease LR; Rodriguez M
J Neurosci; 1998 Oct; 18(19):7700-8. PubMed ID: 9742140
[TBL] [Abstract][Full Text] [Related]
20. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice.
Bosio A; Binczek E; Haupt WF; Stoffel W
J Neurochem; 1998 Jan; 70(1):308-15. PubMed ID: 9422376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
